Staphylococcus aureus infection following nasal colonization: An approach to rapid risk stratification in a university healthcare system

Journal of Hospital Infection

Volumn 79, Issue 4, 2011, Pages 297-301

  Seybold, U ^a   Schubert, S ^b   Bogner, J R ^a   Hogardt, M ^b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Bavarian Health and Food Safety Authority   (Germany)

Author keywords

Colonization; Infection; MRSA; Risk stratification; Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; MOXIFLOXACIN; OXACILLIN; PSEUDOMONIC ACID; RIFAMPICIN;

ADULT; ARTICLE; BACTERIAL COLONIZATION; CASE CONTROL STUDY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOSE INFECTION; RISK FACTOR; SCREENING TEST; STAPHYLOCOCCUS INFECTION; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADULT; AGE FACTORS; CARRIER STATE; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; NASAL CAVITY; RISK ASSESSMENT; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 81055156709     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.08.017     Document Type: Article

References (28)

1. Kuehnert M.J., Kruszon-Moran D., Hill H.A., et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006, 193:172-179.
2. Lietzau S., Sturmer T., Erb A., Von Baum H., Marre R., Brenner H. Prevalence and determinants of nasal colonization with antibiotic-resistant Staphylococcus aureus among unselected patients attending general practitioners in Germany. Epidemiol Infect 2004, 132:655-662.
3. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008, 197:1226-1234.
4. Graham P.L., Lin S.X., Larson E.L. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006, 144:318-325.
5. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10:505-520.
6. Seybold U., Supthut-Schroder B., Draenert R., Hogardt M., Bogner J.R. Prevalence and risk factors of nasal colonization with Staphylococcus aureus - association with HIV infection in older patients. Scand J Infect Dis 2009, 41:63-66.
7. Gordon R.J., Quagliarello B., Cespedes C., et al. A molecular epidemiological analysis of 2 Staphylococcus aureus clonal types colonizing and infecting patients with AIDS. Clin Infect Dis 2005, 40:1028-1036.
8. Boelaert J.R., De Smedt R.A., De Baere Y.A., et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 1989, 4:278-281.
9. von Eiff C., Becker K., Machka K., Stammer H., Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001, 344:11-16.
10. Perl T.M., Cullen J.J., Wenzel R.P., et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002, 346:1871-1877.
11. Wertheim H.F., Vos M.C., Ott A., et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004, 364:703-705.
12. Holtfreter S., Roschack K., Eichler P., et al. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis 2006, 193:1275-1278.
13. Ellis M.W., Hospenthal D.R., Dooley D.P., Gray P.J., Murray C.K. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004, 39:971-979.
14. Wertheim H.F., Melles D.C., Vos M.C., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005, 5:751-762.
15. Davis K.A., Stewart J.J., Crouch H.K., Florez C.E., Hospenthal D.R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004, 39:776-782.
16. Ammerlaan H.S., Kluytmans J.A., Wertheim H.F., Nouwen J.L., Bonten M.J. Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. Clin Infect Dis 2009, 48:922-930.
17. van Rijen M., Bonten M., Wenzel R., Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database System Rev 2008, 4:CD006216.
18. Bode L.G., Kluytmans J.A., Wertheim H.F., et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362:9-17.
19. Kluytmans J.A., Manders M.J., van Bommel E., Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996, 17:793-797.
20. Kluytmans J.A., Mouton J.W., VandenBergh M.F., et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996, 17:780-785.
21. Gordon R.J., Chez N., Jia H., et al. The NOSE Study (Nasal Ointment for Staphylococcus aureus Eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals. J Acquir Immune Defic Syndr 2010, 55:466-472.
22. Wertheim H.F., Vos M.C., Ott A., et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med 2004, 140:419-425.
23. Clinical and Laboratory Standards Institute Principles and procedures for blood cultures 2007, Approved guideline. M47-A, Clinical and Laboratory Standards Institute, Wayne, PA.
24. Clinical and Laboratory Standards Institute Performance standards for antimicrobial disk susceptibility tests 2009, Approved standard, Clinical and Laboratory Standards Institute, Wayne, PA, M02-A10. 10th ed.
25. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2009, Clinical and Laboratory Standards Institute, M07-A8. Wayne, PA. 8th ed.
26. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing 2009, Nineteenth informational supplement. M100-S19, Clinical and Laboratory Standards Institute, Wayne, PA.
27. McCabe R., Reid W.M., Knox W.G. Evaluation of the use of a temporary percutaneous endotracheal catheter in the treatment and prevention of postoperative pulmonary complications. Ann Surg 1962, 156:5-8.
28. Mor V., Laliberte L., Morris J.N., Wiemann M. The Karnofsky performance status scale. An examination of its reliability and validity in a research setting. Cancer 1984, 53:2002-2007.